Controlled-release opioids and alcohol.
作者信息
Darke Andrew C
出版信息
CMAJ. 2006 Jan 31;174(3):352. doi: 10.1503/cmaj.1050210.
Abstract
摘要
相似文献
1
Controlled-release opioids and alcohol.控释阿片类药物与酒精
CMAJ. 2006 Jan 31;174(3):352. doi: 10.1503/cmaj.1050210.
2
Alcohol-associated rapid release of a long-acting opioid.酒精相关的长效阿片类药物快速释放。
CMAJ. 2005 Sep 27;173(7):756. doi: 10.1503/cmaj.051083. Epub 2005 Sep 8.
3
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理：一个国际专家小组的共识声明，重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物（丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮）。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
4
[Delayed action and rapidly effective in combination. Hydromorphone--already a WHO stage 3 drug].[延迟起效但联合使用时迅速有效。氢吗啡酮——已属世界卫生组织三级药物]
MMW Fortschr Med. 2006 May 11;148(19):47.
5
FDA asks Purdue Pharma to withdraw Palladone.
FDA Consum. 2005 Sep-Oct;39(5):7.
6
Oral hydromorphone extended-release.口服缓释氢吗啡酮
Consult Pharm. 2010 Dec;25(12):816-28. doi: 10.4140/TCP.n.2010.816.
7
The metamorphosis of hydromorphone.氢吗啡酮的变质
J Opioid Manag. 2005 Jul-Aug;1(3):139-45. doi: 10.5055/jom.2005.0033.
8
Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules.每日一次盐酸氢吗啡酮缓释胶囊的临床药理学与药代动力学
J Clin Pharmacol. 2005 May;45(5):547-54. doi: 10.1177/0091270005274552.
9
[Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study].
MMW Fortschr Med. 2004 Dec 2;146(49):45.
10
Hydromorphone-OROS formulation.氢吗啡酮控释制剂。
Expert Opin Pharmacother. 2010 May;11(7):1207-14. doi: 10.1517/14656566.2010.482099.
本文引用的文献
1
Alcohol-associated rapid release of a long-acting opioid.酒精相关的长效阿片类药物快速释放。
CMAJ. 2005 Sep 27;173(7):756. doi: 10.1503/cmaj.051083. Epub 2005 Sep 8.
Zotero 插件